Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 feeds
299 followers
43 artículos por semana
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
Bristol Myers Squibb axes 79 more in New Jersey as $1.5B cost-reduction program rolls on
After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa
321 followers
41 artículos por semana
After Alzheimer's stumble, Athira lays off 70% of workforce and pivots to ALS small molecule
Stryker strikes again, acquiring brain surgery devicemaker Nico
Protein found in hibernating squirrels could become first cataract drug treatment: study
Politan prevails in Masimo proxy fight, gaining 2 board seats and ousting CEO Joe Kiani
Reporting from the frontiers of health and medicine
619 followers
78 artículos por semana
Opinion: First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
Second health care worker tied to Missouri bird flu case had respiratory symptoms
STAT+: PhRMA scores a small win in legal challenge to Medicare’s drug price negotiation
FDA approves first at-home flu vaccine in U.S., a nasal spray
Contains all the PharmaTimes latest World News.
316 followers
5 artículos por semana
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
SeguirThe latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
486 followers
5 artículos por semana
BioPharma
305 followers
24 artículos por semana
441 followers
5 artículos por semana
Events
300 followers
4 artículos por semana
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.